I
iRhythm Technologies
Wearable biosensors for continuous cardiac arrhythmia monitoring, with the Zio patch as the flagship product
At a glance
- Status
- Listed
- Founded
- 2006
- Headquarters
- San Francisco, United States
- Listing
- IPO 2016
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
- SMSt. Jude Medical
- SPSynergy Life Science Partner
- MVMohr Davidow Ventures
- TITBJ Investments
Series B and later5 investors entered at this stage
- NSNovo Seeds
- KVKaiser Permanente Ventures
- NHNovo Holdings
- NPNew Leaf Venture Partners
Norwest Venture Partners
Source: Dealroom Talent Intelligence.
Alumni founders
Former iRhythm Technologies employees who went on to found companies, sorted by Dealroom signal score.
ESElement ScienceEst. 2013
Uday KumarUnited States
KYKyteEst. 2019Global footprint
team presence
across markets
Patents
20 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about iRhythm Technologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See iRhythm Technologies on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.